Viewing Study NCT02470702


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-22 @ 3:58 AM
Study NCT ID: NCT02470702
Status: COMPLETED
Last Update Posted: 2023-12-19
First Post: 2015-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
Sponsor: Melinta Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module